Sign in to view content

BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing

Eric W Schneider, MD

Video
Published 2019

Related

Does Anti-VEGF Therapy Affect the Rate of Expansion of Geographic Atrophy in Patients with Neovascular AMD Managed by a Treat-Extend-Stop Protocol?
Sean David Adrean, MD, FAAO, FASRS
On Demand Cases, Courses, and Papers
2019
Higher-Order OCT Analysis From the HAWK Study: Longitudinal Dynamics in Fluid Burden, Outer Retinal Integrity, and Subretinal Hyperreflective Material
Justis P. Ehlers, MD, FASRS
On Demand Cases, Courses, and Papers
2021
Additional Visual and Anatomic Outcomes of Intravitreal Aflibercept Injection, 8 mg vs 2 mg: Post Hoc Analysis of the Phase 2 CANDELA Study
Priya Sharma Vakharia, MD
Annual Meeting Talks
2023

Category: AMD-Neovascular

See more